ARCHIVE
2019
2018
2016
2015
2014
Mundipharma establishes an ophthalmology business by acquiring MSD’s portfolio of glaucoma products
Published on December 3, 2015The portfolio consists of COSOPT®, COSOPT® Preservative-Free, SAFLUTAN®, TIMOPTIC®, TIMOPTIC XE®, TIMOPTIC® Preservative-Free, TRUSOPT® and…
Read MoreMUNDIPHARMA EXPANDS SPECIALISED CANCER TREATMENT PORTFOLIO WITH THE ACQUISITION OF SPECTRUM’S JAPAN AFFILIATE AND MULTI-MARKET ZEVALIN® ACQUISITION
Published on November 18, 2015Acquisition from Spectrum Pharmaceuticals leverages upon Mundipharma’s existing regulatory and marketing investments. Under the License…
Read MoreMundipharma Expands Specialised Cancer Treatment Portfolio with the Acquisition of Spectrum’s Japan Affiliate and Multi-market ZEVALIN® Acquisition
Published on November 18, 2015Acquisition from Spectrum Pharmaceuticals leverages upon Mundipharma’s existing regulatory and marketing investments. Under the License…
Read MoreTennis Star Caroline Wozniacki and Mundipharma Announce Partnership in GUINNESS WORLD RECORDSTM Setting Style
Published on October 30, 2015The 23-time WTA tournament winner’s international appeal to drive new marketing campaign for the BETADINE®…
Read More For all media enquiries, please contact:
Carole Kamalini – Corporate Communications
carole.kamalanathan@mundipharma.com.my
+(603) 7946 0606
